Study of surgery details in pancreatic cancer patients
Part of Cancer clinical trials.
This study looks at pancreatic cancer patients who undergo planned surgery and how surgery-related factors relate to outcomes. It especially focuses on pre-surgery CT scans and the “margin” status from the pathology report, which may help doctors better plan treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are having planned surgery for your first (primary) pancreatic cancer, or you had treatment first (neoadjuvant) and then surgery
- You had a CT scan with two phases before surgery to plan and stage the cancer
- If you had treatment before surgery, you also had CT scans before and after that treatment
- Your surgical pathology “margin” evaluation (CRM) must be done using the study center’s protocol
- Detailed surgical information will be collected (for example, whether certain parts were preserved or whether any vessel/artery was removed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps people going for planned pancreatic cancer surgery (with or without chemo beforehand) by focusing on controllable risk factors before the operation. The goal is to improve safety and outcomes after surgery.
This study looks at people with borderline-resectable or locally advanced pancreatic cancer to see how treatment choices affect survival, quality of life, and whether tumors can be removed by surgery. It may help doctors better predict who can benefit from surgical approaches and what outcomes matter most to patients.
This study looks at what features of certain pancreas and nearby tumors or cysts might help predict outcomes. It uses existing medical records (and consent, if applicable) and may help doctors better estimate prognosis for patients in the future.
This study compares two ways of doing pancreaticoduodenectomy (a major surgery to remove parts of the pancreas and nearby tissue): minimally invasive (often smaller incisions) versus open surgery. It may help clarify which approach works best when the cancer looks potentially removable.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study looks at patients who had surgery to remove pancreatic cancer to understand what factors might lead to the cancer coming back early. If you have had surgery for pancreatic cancer and are interested in helping researchers learn more, this may be a fit.
Hear when a new PDAC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.